CNTX is trading 6.3% up today at $0.59, continuing a modest rebound after heavy longer-term downside pressure.
- The gain appears to be a technical bounce following recent volatility rather than a reaction to fresh news.
- There are no new company-specific headlines, earnings releases, FDA decisions, or major analyst calls dated July 01, 2026, to explain the move.